基于网络药理学和动物实验探讨好忘方治疗血管性痴呆作用机制OA
Exploration on the Mechanism of Haowang Prescription in Treating Vascular Dementia Based on Network Pharmacology and Animal Experiments
目的 基于网络药理学及动物实验探讨好忘方治疗血管性痴呆(VD)的作用机制.方法 通过TCMSP数据库检索好忘方的有效成分及相关靶点,OMIM和GeneCards数据库搜集VD靶点,STRING数据库构建靶蛋白相互作用网络,R4.4.2软件对关键靶点进行GO和KEGG富集分析.采用改良双侧颈动脉结扎法制备VD大鼠模型,将成模大鼠分为模型组、多奈哌齐组、好忘方低剂量组、好忘方高剂量组、好忘方高剂量+AMPK抑制剂(Compound C)组,另设假手术组,并予相应干预.Morris水迷宫实验检测大鼠学习记忆能力,HE染色观察海马CA1区组织形态,透射电镜观察海马神经元线粒体形态和结构,ELISA检测海马组织炎症因子含量,流式细胞术检测海马组织线粒体膜电位及活性氧(ROS)含量,Western blot、实时荧光定量PCR分别检测海马组织核心靶点及通路的蛋白和mRNA表达.结果 网络药理学筛选出好忘方活性成分39个、治疗VD的主要靶点91个,核心靶点为PINK1、NLRP3、CASP1、GSDMD、IL1B、PARK2、SQSTM1、TOM7、TNF、ROS1;KEGG通路富集分析提示,AMPK信号通路、线粒体自噬信号通路、NOD样受体信号通路、自噬及mTOR信号通路可能起核心调控作用.动物实验结果显示,好忘方能够提高模型大鼠的学习、空间记忆能力(P<0.05,P<0.01);减轻海马组织病理形态学损伤,减轻海马组织线粒体形态和结构损伤;降低海马组织IL-1β、IL-18、TNF-α及ROS含量,升高线粒体膜电位,上调AMPK、PINK1、Parkin、LC3B蛋白及mRNA表达,下调p62、TOMM20、NLRP3、ASC、Caspase-1、GSDMD-N蛋白及mRNA表达(P<0.05,P<0.01).AMPK抑制剂可部分逆转好忘方对线粒体自噬和细胞焦亡的效果.结论 好忘方可减少VD大鼠海马组织细胞焦亡,其机制可能与其激活AMPK/PINK1/Parkin介导的线粒体自噬通路有关.
Objective To explore the mechanism of Haowang Prescription in the treatment of vascular dementia(VD)using network pharmacology and animal experiments.Methods Active components and corresponding targets of Haowang Prescription were retrieved from the TCMSP databases;the targets of VD were obtained through the OMIM and GeneCards databases.The protein-protein interaction network was established through STRING database.GO and KEGG enrichment analyses of key targets were carried out by using R language.The VD rat model was established by modified bilateral carotid artery ligation.The modeled rats were divided into model group,donepezil group,Haowang Prescription low-dosage group,Haowang Prescription high-dosage group,Haowang Prescription high-dosage+AMPK inhibitor(Compound C)group,and the sham-operation group was set up.The corresponding intervention was given.The learning and memory abilities of rats were tested by Morris water maze test.The pathomorphological changes in the hippocampus were observed by HE staining.Transmission electron microscopy was employed to observe mitochondrial morphology in hippocampus neurons.The content of inflammatory factors in hippocampus was detected by ELISA.Flow cytometry was used to detect changes in mitochondrial membrane potential and the level of reactive oxygen species(ROS).The expressions of proteins and mRNA of core targets and pathways in the hippocampus were detected by Western blot and RT-qPCR.Results A total of 39 active components of Haowang Prescription and 91 main targets for treating VD were screened,with the core targets including PINK1,NLRP3,CASP1,GSDMD,IL1B,PARK2,SQSTM1,TOM7,TNF and ROS1.KEGG pathway enrichment analysis suggested that AMPK signaling pathway,mitophagy,NOD-like receptor signaling pathway,autophagy and mTOR signaling pathway may play a core regulatory role.Animal experiments showed that Haowang Prescription could significantly improve the learning and spatial memory abilities of model rats(P<0.05,P<0.01),alleviate pathological morphology damage in hippocampal tissue,and alleviate mitochondrial morphological and structural damage in hippocampal tissue.The contents of IL-1β,IL-18,TNF-α and ROS in hippocampus decreased significantly;the mitochondrial membrane potential significantly increased,the expressions of AMPK,PINK1,Parkin,LC3B protein and mRNA were up-regulated,and the expressions of p62,TOMM20,NLRP3,ASC,Caspase-1,GSDMD-N proteins and mRNA were down-regulated(P<0.05,P<0.01).AMPK inhibitor partially reversed the therapeutic effects of Haowang Prescription on mitophagy and pyroptosis.Conclusion Haowang Prescription can reduce pyroptosis in hippocampal tissues of VD rats,and the mechanism may be related to its activation of AMPK/PINK1/Parkin-mediated mitophagy.
张运辉;杨梦琳;李勇华;伍大华;杨昆;刘霞;程妍
重庆三峡医药高等专科学校,重庆 404120重庆三峡医药高等专科学校,重庆 404120重庆三峡医药高等专科学校,重庆 404120湖南中医药大学,湖南 长沙 410208||湖南省中医药研究院附属医院,湖南 长沙 410006重庆三峡医药高等专科学校,重庆 404120重庆三峡医药高等专科学校,重庆 404120重庆三峡医药高等专科学校,重庆 404120
医药卫生
好忘方网络药理学血管性痴呆线粒体自噬细胞焦亡
Haowang Prescriptionnetwork pharmacologyvascular dementiamitophagypyroptosis
《中国中医药信息杂志》 2026 (9)
17-26,10
国家自然科学基金(82374441)重庆市中医药传承创新团队-三峡库区道地药材保护与利用多学科交叉创新团队(CXTD202303)重庆三峡医药高等专科学校高层次人才科研启动基金(XJ2023004401)重庆市中医药管理局针灸推拿智能装备重点实验室(ZJZNZB202501)重庆市中医药重点学科(中医基础理论)建设项目(渝中医[2021]16号)重庆三峡医药高等专科学校呼吸和老年疾病中医药防治创新研究中心(CXZX202402)重庆三峡医药高等专科学校中医药防治呼吸和老年病团队(TIG202302)
评论